We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

By LabMedica International staff writers
Posted on 28 Oct 2024
Print article
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common blood test that screens for various conditions, including anemia, infection, leukemia, and bleeding. It measures the levels of red and white blood cells as well as platelets. Now, an enhanced diagnostic system aims to provide lab-quality results at lab-grade costs at the patient’s side for this frequently ordered test, which serves as the first line of triage. This system intends to be the most comprehensive patient-side CBC and the first to report immature granulocytes and the neutrophil-to-lymphocyte ratio in community settings, such as physician offices, cancer centers, and ambulances, facilitating earlier identification and triage of severe infections.

Ad Astra Diagnostics (AAD, Morrisville, NC, USA) is developing the user-friendly QScout CBC to deliver quicker CBC test results and enable the earlier detection of severe infections, including sepsis. The QScout CBC measures immature granulocytes, which are early markers of sepsis. AAD's QScout CBC system is being created as the next generation of the company’s QScout RLD, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA) following successful field trials that compared it to central lab tests.

The QScout CBC system will incorporate various enhancements, such as a smaller physical footprint and broader diagnostic capabilities, including faster and more straightforward CBC testing. This innovative system is essentially a "lab in a box," as it contains a computer, microscope, camera, and robotics. To conduct a test, the user simply places a blood sample obtained from a finger stick or venous draw onto a low-cost test cartridge and inserts it into the QScout Lab. There is no need for sample preparation. The system then utilizes artificial intelligence-trained algorithms to identify cells and cellular parameters, providing a test result in approximately two minutes.

"Coupling a full CBC with a sepsis risk score on a small, simple and rugged platform expands the market and increases access to on-site critical testing and early identification of severe illness and sepsis to help prevent unnecessary deaths from infection," said Joy Parr Drach, CEO of AAD.

Related Links:
Ad Astra Diagnostics

New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Unit-Dose Packaging solution
HLX
New
LH ELISA
Luteinizing Hormone ELISA
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Scientists have developed tool to predict sepsis in apparently healthy newborns (Photo courtesy of 123RF)

Genetic Signature in Newborns Predicts Neonatal Sepsis Before Symptoms Appear

Neonatal sepsis, which occurs due to the body’s abnormal response to severe infection within the first 28 days of life, results in approximately 200,000 deaths globally each year. This condition affects around 1.... Read more

Immunology

view channel
Image: Low NBR1 levels in hepatic stellate cells enhance interferon signaling in human hepatocellular carcinoma (Photo courtesy of Moscat and Diaz-Meco labs)

Biomarker Could Predict Immunotherapy Response in Liver Cancer

Until recently, patients diagnosed with hepatocellular carcinoma had limited treatment options, with existing therapies extending life by only a few months. Immunotherapy has emerged as a new alternative... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.